Founded in 1987, Chemagis is a subsidiary of Perrigo Israel (PIL) , Israel's second largest pharmaceutical conglomerate and part of the Perrigo Group (PRGO) - the world’s largest manufacturer of over-the-counter (OTC) pharmaceutical and nutritional products for the store-brand market.   

 

Chemagis develops, produces and markets an extensive line of high-quality Active Pharmaceutical Ingredients (APIs) and Finished Dosage Forms (FDF) for the branded and generic pharmaceutical industries. Its products comply with the exacting regulatory requirements of leading health authorities including the FDA, MCA, TGA and HPB, while its facilities in Israel and Germany are FDA-inspected and cGMP-compliant.

 

Leveraging its strengths in complex chemistry, patents and in-depth regulatory expertise, and propelled by a team of experts and creative scientists, Chemagis provides tailor-made solutions to meet individual requirements - regardless of complexity.  We offer our customers comprehensive, customized packages consisting of IP assets, API products, dossiers, FDF, bundling and P-IV partnerships - some through joint ventures and some independently - all complemented by strategic alliances.

 

Chemagis also offers complete technical and regulatory support from project inception through to final production. Applying high efficiency and control measures during the entire supply, development and manufacturing chain, and throughout the product lifecycle, Chemagis provides outstanding value to hundreds of customers worldwide.